MENU
+Compare
ARGX
Stock ticker: NASDAQ
AS OF
Jul 21, 01:10 PM (EDT)
Price
$565.14
Change
-$7.57 (-1.32%)
Capitalization
34.97B

ARGX argenx SE Forecast, Technical & Fundamental Analysis

Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases... Show more

ARGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ARGX with price predictions
Jul 18, 2025

ARGX's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for ARGX turned positive on July 09, 2025. Looking at past instances where ARGX's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ARGX's RSI Oscillator exited the oversold zone, of 21 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 10, 2025. You may want to consider a long position or call options on ARGX as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

ARGX moved above its 50-day moving average on July 16, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ARGX advanced for three days, in of 300 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARGX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ARGX broke above its upper Bollinger Band on July 16, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ARGX entered a downward trend on July 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ARGX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.285) is normal, around the industry mean (18.143). P/E Ratio (34.426) is within average values for comparable stocks, (58.647). ARGX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.460). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (14.620) is also within normal values, averaging (270.975).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
ARGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ARGX is expected to report earnings to rise 18.60% to $3.06 per share on July 31

argenx SE ARGX Stock Earnings Reports
Q2'25
Est.
$3.06
Q1'25
Beat
by $0.34
Q4'24
Beat
by $10.57
Q3'24
Beat
by $1.24
Q2'24
Beat
by $1.35
The last earnings report on May 08 showed earnings per share of $2.58, beating the estimate of $2.24. With 19.13K shares outstanding, the current market capitalization sits at 34.97B.
A.I. Advisor
published General Information

General Information

a manufacturer of antibody-based medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
Laarderhoogtweg 25
Phone
+31 107038441
Employees
1148
Web
https://www.argenx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
WTMF35.92-0.01
-0.03%
WisdomTree Managed Futures Strategy ETF
ESN16.14-0.04
-0.23%
Essential 40 Stock ETF
SDVY36.02-0.12
-0.33%
First Trust SMID Cp Rising Div Achv ETF
NDMO9.87-0.08
-0.80%
Nuveen Dynamic Municipal Opportunities Fund
OILU22.29-0.48
-2.11%
MicroSectorsTM Oil&Gs Exp&Pd 3X Lvg ETNs

ARGX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ARGX has been loosely correlated with IONS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ARGX jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARGX
1D Price
Change %
ARGX100%
N/A
IONS - ARGX
44%
Loosely correlated
-0.97%
ROIV - ARGX
43%
Loosely correlated
-1.80%
MTVA - ARGX
43%
Loosely correlated
+0.43%
ALNY - ARGX
42%
Loosely correlated
-1.28%
GMAB - ARGX
40%
Loosely correlated
-0.59%
More